Last updated: 2026-09-06 04:23:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Curanex Pharmaceuticals Inc. (CURX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.08, with a market capitalization of $7.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.58 to $183.59. This page covers its latest market performance, valuation, price trends and company information.
$7.13M | |
$4.74 | |
$183.59 | |
$3.58 | |
$4.74 | |
13.78K | |
-- | |
-- | |
$183.59 | |
$3.58 | |
-- | |
-- |
Curanex Pharmaceuticals Inc. (CURX) last closed at $4.74 as of 2026-09-04 23:31:00, unchanged from the previous close of $4.74.
During the latest regular trading session, CURX traded between $3.58 and $183.59, with a volume of 13.78K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Curanex Pharmaceuticals Inc. (CURX) moved from $4.54 to $5.08, representing a gain of 11.89% ($0.54).
The stock traded between $4.65 and $5.36 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 9.89 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.8%
CURX is currently trading at $5.08, placing it 0.8% of the way from its 52-week low of $3.58 to its 52-week high of $183.59. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Curanex Pharmaceuticals Inc. (CURX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.